DNB Carnegie Access: EQL Pharma: From reset to recovery – Q3 2025/26 preview
DNB Carnegie has published a new commissioned research report on EQL Pharma
To access the full report and subscribe to future updates, visit https://access.dnbcarnegie.com/companies/1387